
    
      This study is a prospective, multi-center, single-arm clinical evaluation of the AVJ-514
      System for the treatment of symptomatic chronic severe mitral regurgitation (MR) in Japanese
      subjects deemed difficult for mitral valve surgery by the local site heart team.

      Patients will be evaluated at baseline, discharge, 30 days, 6 months, 1 year, 2 years, 3
      years, 4 years, and 5 years in Japanese Medical Centers.
    
  